
Hau Van Phan
Examiner (ID: 8779, Phone: (571)272-6696 , Office: P/3618 )
| Most Active Art Unit | 3618 |
| Art Unit(s) | 3618, 3613, 3615, 3619, 3611 |
| Total Applications | 2398 |
| Issued Applications | 1830 |
| Pending Applications | 100 |
| Abandoned Applications | 497 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19490621
[patent_doc_number] => 12109306
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Hydrocortisone acetate suppository formulation for treatment of disease
[patent_app_type] => utility
[patent_app_number] => 18/588892
[patent_app_country] => US
[patent_app_date] => 2024-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 12881
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18588892
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/588892 | Hydrocortisone acetate suppository formulation for treatment of disease | Feb 26, 2024 | Issued |
Array
(
[id] => 19503854
[patent_doc_number] => 12115252
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-15
[patent_title] => Hydrocortisone acetate suppository formulation for treatment of disease
[patent_app_type] => utility
[patent_app_number] => 18/588938
[patent_app_country] => US
[patent_app_date] => 2024-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 12882
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18588938
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/588938 | Hydrocortisone acetate suppository formulation for treatment of disease | Feb 26, 2024 | Issued |
Array
(
[id] => 19401974
[patent_doc_number] => 20240285485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => WATER-IN-OIL TYPE SOLID EMULSIFIED COSMETIC PREPARATION
[patent_app_type] => utility
[patent_app_number] => 18/586718
[patent_app_country] => US
[patent_app_date] => 2024-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18586718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/586718 | WATER-IN-OIL TYPE SOLID EMULSIFIED COSMETIC PREPARATION | Feb 25, 2024 | Pending |
Array
(
[id] => 19232287
[patent_doc_number] => 20240189479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => Cardiovascular Prostheses
[patent_app_type] => utility
[patent_app_number] => 18/442571
[patent_app_country] => US
[patent_app_date] => 2024-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18442571
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/442571 | Cardiovascular Prostheses | Feb 14, 2024 | Pending |
Array
(
[id] => 19331409
[patent_doc_number] => 20240245839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => COMPOSITIONS AND DEVICES INCORPORATING WATER-INSOLUBLE THERAPEUTIC AGENTS AND METHODS OF THE USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/437509
[patent_app_country] => US
[patent_app_date] => 2024-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18437509
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/437509 | COMPOSITIONS AND DEVICES INCORPORATING WATER-INSOLUBLE THERAPEUTIC AGENTS AND METHODS OF THE USE THEREOF | Feb 8, 2024 | Pending |
Array
(
[id] => 19316938
[patent_doc_number] => 20240238478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => TUNABLE, CONTROLLED-RELEASE, URETHANE-CONTAINING ELASTOMERS AND PROCESSES OF FORMING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/425208
[patent_app_country] => US
[patent_app_date] => 2024-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18425208
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/425208 | TUNABLE, CONTROLLED-RELEASE, URETHANE-CONTAINING ELASTOMERS AND PROCESSES OF FORMING THE SAME | Jan 28, 2024 | Abandoned |
Array
(
[id] => 19279857
[patent_doc_number] => 20240216329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => PUTRESCINE TOPICAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/423569
[patent_app_country] => US
[patent_app_date] => 2024-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18423569
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/423569 | PUTRESCINE TOPICAL FORMULATIONS | Jan 25, 2024 | Pending |
Array
(
[id] => 19156283
[patent_doc_number] => 20240148990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS
[patent_app_type] => utility
[patent_app_number] => 18/417683
[patent_app_country] => US
[patent_app_date] => 2024-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18417683
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/417683 | DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS | Jan 18, 2024 | Pending |
Array
(
[id] => 19316667
[patent_doc_number] => 20240238207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => Encased Tamper Resistant Controlled Release Dosage Forms
[patent_app_type] => utility
[patent_app_number] => 18/416293
[patent_app_country] => US
[patent_app_date] => 2024-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18416293
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/416293 | Encased Tamper Resistant Controlled Release Dosage Forms | Jan 17, 2024 | Abandoned |
Array
(
[id] => 19155936
[patent_doc_number] => 20240148642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => CELL HOUSING DEVICE
[patent_app_type] => utility
[patent_app_number] => 18/415877
[patent_app_country] => US
[patent_app_date] => 2024-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36821
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18415877
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/415877 | CELL HOUSING DEVICE | Jan 17, 2024 | Pending |
Array
(
[id] => 19387721
[patent_doc_number] => 20240277591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => TOPICAL SKIN COMPOSITIONS FOR TREATING WRINKLES
[patent_app_type] => utility
[patent_app_number] => 18/415019
[patent_app_country] => US
[patent_app_date] => 2024-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18415019
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/415019 | TOPICAL SKIN COMPOSITIONS FOR TREATING WRINKLES | Jan 16, 2024 | Abandoned |
Array
(
[id] => 19155940
[patent_doc_number] => 20240148646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS
[patent_app_type] => utility
[patent_app_number] => 18/411663
[patent_app_country] => US
[patent_app_date] => 2024-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18411663
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/411663 | Dry powder formulations of epinephrine and associated methods | Jan 11, 2024 | Issued |
Array
(
[id] => 19541678
[patent_doc_number] => 20240358714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT
[patent_app_type] => utility
[patent_app_number] => 18/402042
[patent_app_country] => US
[patent_app_date] => 2024-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18402042
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/402042 | PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT | Jan 1, 2024 | Pending |
Array
(
[id] => 19331343
[patent_doc_number] => 20240245773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => FRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY WITH AN OXYGEN THERAPEUTIC
[patent_app_type] => utility
[patent_app_number] => 18/401652
[patent_app_country] => US
[patent_app_date] => 2024-01-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18401652
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/401652 | FRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY WITH AN OXYGEN THERAPEUTIC | Dec 31, 2023 | Pending |
Array
(
[id] => 19883100
[patent_doc_number] => 12268784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Polylactic acid microsphere, polylactic-co-glycolic acid microsphere and method of preparing the same
[patent_app_type] => utility
[patent_app_number] => 18/397342
[patent_app_country] => US
[patent_app_date] => 2023-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 8282
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18397342
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/397342 | Polylactic acid microsphere, polylactic-co-glycolic acid microsphere and method of preparing the same | Dec 26, 2023 | Issued |
Array
(
[id] => 19608019
[patent_doc_number] => 12156878
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-12-03
[patent_title] => Compositions and methods for minimizing effects of alcohol intoxication
[patent_app_type] => utility
[patent_app_number] => 18/395565
[patent_app_country] => US
[patent_app_date] => 2023-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9352
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18395565
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/395565 | Compositions and methods for minimizing effects of alcohol intoxication | Dec 22, 2023 | Issued |
Array
(
[id] => 19096263
[patent_doc_number] => 20240115490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => DRUG DELIVERY SYSTEM FOR ULTRA-LOW DOSE ESTROGEN COMBINATIONS AND METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/391538
[patent_app_country] => US
[patent_app_date] => 2023-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18391538
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/391538 | DRUG DELIVERY SYSTEM FOR ULTRA-LOW DOSE ESTROGEN COMBINATIONS AND METHODS AND USES THEREOF | Dec 19, 2023 | Pending |
Array
(
[id] => 19081925
[patent_doc_number] => 20240108726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 18/539830
[patent_app_country] => US
[patent_app_date] => 2023-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18539830
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/539830 | METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT | Dec 13, 2023 | Pending |
Array
(
[id] => 19472620
[patent_doc_number] => 12102683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Pharmaceutical composition of diltiazem hydrochloride, preparation method therefor, and application thereof
[patent_app_type] => utility
[patent_app_number] => 18/529137
[patent_app_country] => US
[patent_app_date] => 2023-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7257
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18529137
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/529137 | Pharmaceutical composition of diltiazem hydrochloride, preparation method therefor, and application thereof | Dec 4, 2023 | Issued |
Array
(
[id] => 19032337
[patent_doc_number] => 20240082152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => NEBULIZATION FORMULATIONS FOR DELIVERY TO LOWER RESPIRATORY TRACT
[patent_app_type] => utility
[patent_app_number] => 18/519955
[patent_app_country] => US
[patent_app_date] => 2023-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18519955
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/519955 | Nebulization formulations for delivery to lower respiratory tract | Nov 26, 2023 | Issued |